Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
McKinsey
Moodys
Johnson and Johnson

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for MYORISAN

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for MYORISAN (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $25,114,864
INSIDE ANOTHER STORE $10,152,620
[disabled in preview] $177,163,160
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 83,110
INSIDE ANOTHER STORE 25,367
[disabled in preview] 166,128
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $85,312,966
PRIVATE INSURANCE $121,375,523
[disabled in preview] $5,742,154
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for MYORISAN
Drug Units Sold Trends for MYORISAN

Annual Sales Revenues and Units Sold for MYORISAN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
MYORISAN   Start Trial   Start Trial 2017
MYORISAN   Start Trial   Start Trial 2016
MYORISAN   Start Trial   Start Trial 2015
MYORISAN   Start Trial   Start Trial 2014
MYORISAN   Start Trial   Start Trial 2013
MYORISAN   Start Trial   Start Trial 2012
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
AstraZeneca
Dow
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.